Jacobs Levy Equity Management, Inc Ars Pharmaceuticals, Inc. Comm Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 101,397 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,397
Previous 653,048 84.47%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-551,651 Reduced 84.47%
101,397 $0
Q3 2024

Nov 14, 2024
BUY
N/A
288,021 Added 78.9%
653,048 $0
Q2 2024

Aug 14, 2024
BUY
N/A
87,321 Added 31.44%
365,027 $0
Q1 2024

May 15, 2024
BUY
N/A
257,589 Added 1280.45%
277,706 $0
Q4 2023

Feb 14, 2024
BUY
N/A
20,117 New
20,117 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-257,368 Reduced 87.16%
37,903 $0
Q1 2023

May 15, 2023
SELL
N/A
-3,345 Reduced 1.12%
295,271 $0
Q4 2022

Feb 14, 2023
SELL
N/A
-152,218 Reduced 33.76%
298,616 $0
Q3 2022

Nov 15, 2022
BUY
N/A
450,834 New
450,834 $2.38 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email